Insider Transactions in Q3 2023 at Ani Pharmaceuticals Inc (ANIP)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,333
-2.29%
|
$1,545,313
$61.23 P/Share
|
|
Sep 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
8,425
-0.75%
|
$513,925
$61.64 P/Share
|
|
Sep 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
16,242
-1.43%
|
$1,007,004
$62.81 P/Share
|
|
Sep 12
2023
|
Krista Davis SVP, CHIEF HR OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,486
-4.05%
|
$90,646
$61.91 P/Share
|
|
Sep 08
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,646
-1.03%
|
$222,406
$61.94 P/Share
|
|
Sep 01
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-6.0%
|
$1,280,000
$64.7 P/Share
|
|
Aug 29
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,000
-2.16%
|
$1,575,000
$63.37 P/Share
|
|
Aug 28
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
25,000
-2.11%
|
$1,575,000
$63.06 P/Share
|
|
Aug 23
2023
|
Ori Gutwerg SVP, GENERICS |
SELL
Open market or private sale
|
Direct |
15,561
-10.46%
|
$964,782
$62.39 P/Share
|
|
Aug 23
2023
|
Ori Gutwerg SVP, GENERICS |
BUY
Exercise of conversion of derivative security
|
Direct |
13,502
+15.01%
|
$418,562
$31.49 P/Share
|
|
Aug 23
2023
|
James G. Marken SVP OPS & PROD DEV |
SELL
Open market or private sale
|
Direct |
3,932
-2.87%
|
$247,716
$63.0 P/Share
|
|
Aug 23
2023
|
James G. Marken SVP OPS & PROD DEV |
BUY
Exercise of conversion of derivative security
|
Direct |
5,417
+1.95%
|
$195,012
$36.8 P/Share
|
|
Aug 21
2023
|
Matthew J Leonard Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,583
+50.0%
|
-
|
|
Aug 16
2023
|
Meridian Venture Partners Ii LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-9.9%
|
$11,600,000
$58.5 P/Share
|
|
Aug 15
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
22,110
-1.84%
|
$1,348,710
$61.6 P/Share
|
|
Aug 15
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
11,616
-3.18%
|
$708,576
$61.13 P/Share
|
|
Aug 15
2023
|
Nikhil Lalwani PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,616
+3.08%
|
$336,864
$29.0 P/Share
|
|
Aug 14
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
27,890
-2.26%
|
$1,701,290
$61.15 P/Share
|
|
Aug 14
2023
|
Stephen P. Carey SVP & CFO |
SELL
Open market or private sale
|
Direct |
17,639
-10.17%
|
$1,075,979
$61.37 P/Share
|
|
Aug 14
2023
|
Antonio R Pera Director |
SELL
Open market or private sale
|
Direct |
3,000
-8.19%
|
$180,000
$60.37 P/Share
|
|
Aug 11
2023
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
56,666
-13.82%
|
$3,229,962
$57.75 P/Share
|
|
Aug 01
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.66%
|
$1,020,000
$51.06 P/Share
|
|
Jul 21
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
11,500
-0.92%
|
$598,000
$52.56 P/Share
|
|
Jul 20
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,000
-0.48%
|
$306,000
$51.52 P/Share
|
|
Jul 19
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
5,969
-0.48%
|
$304,419
$51.48 P/Share
|
|
Jul 18
2023
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,743
-4.41%
|
$88,893
$51.89 P/Share
|
|
Jul 18
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
6,700
-0.53%
|
$341,700
$51.84 P/Share
|
|
Jul 17
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
9,831
-0.77%
|
$501,381
$51.06 P/Share
|
|
Jul 14
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Indirect |
10,000
-0.78%
|
$500,000
$50.43 P/Share
|
|
Jul 03
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.36%
|
$1,060,000
$53.43 P/Share
|